These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

359 related items for PubMed ID: 19906090

  • 1. A rescue therapy with a combination of caspofungin and liposomal amphotericin B or voriconazole in children with haematological malignancy and refractory invasive fungal infections.
    Yilmaz D, Balkan C, Ay Y, Akin M, Karapinar B, Kavakli K.
    Mycoses; 2011 May; 54(3):234-42. PubMed ID: 19906090
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Clinical experience of the use of voriconazole, caspofungin or the combination in primary and salvage therapy of invasive aspergillosis in haematological malignancies.
    Raad II, Zakhem AE, Helou GE, Jiang Y, Kontoyiannis DP, Hachem R.
    Int J Antimicrob Agents; 2015 Mar; 45(3):283-8. PubMed ID: 25455847
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Outcome analysis of caspofungin in combination with voriconazole for treatment of 12 hematologic malignancies cases with invasive fungal infection].
    Sun HL, Zhou X, Shen YF.
    Zhonghua Xue Ye Xue Za Zhi; 2011 Aug; 32(8):558-9. PubMed ID: 22338183
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Caspofungin associated with liposomal amphotericin B or voriconazole for treatment of refractory fungal pneumonia in children with acute leukaemia or undergoing allogeneic bone marrow transplant.
    Castagnola E, Machetti M, Cappelli B, Molinari AC, Morreale G, Dodero P, Tomà P, Faraci M.
    Clin Microbiol Infect; 2004 Mar; 10(3):255-7. PubMed ID: 15008948
    [Abstract] [Full Text] [Related]

  • 12. Caspofungin versus liposomal amphotericin B for empirical therapy.
    Marty FM, Lowry CM.
    N Engl J Med; 2005 Jan 27; 352(4):410-4; author reply 410-4. PubMed ID: 15675093
    [No Abstract] [Full Text] [Related]

  • 13. Refractory Aspergillus pneumonia in patients with acute leukemia: successful therapy with combination caspofungin and liposomal amphotericin.
    Aliff TB, Maslak PG, Jurcic JG, Heaney ML, Cathcart KN, Sepkowitz KA, Weiss MA.
    Cancer; 2003 Feb 15; 97(4):1025-32. PubMed ID: 12569602
    [Abstract] [Full Text] [Related]

  • 14. Antifungal therapy in patients with hematological malignancies: how to avoid overtreatment?
    Cherif H, Kalin M, Björkholm M.
    Eur J Haematol; 2006 Oct 15; 77(4):288-92. PubMed ID: 16856930
    [Abstract] [Full Text] [Related]

  • 15. Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children.
    Walsh TJ, Lutsar I, Driscoll T, Dupont B, Roden M, Ghahramani P, Hodges M, Groll AH, Perfect JR.
    Pediatr Infect Dis J; 2002 Mar 15; 21(3):240-8. PubMed ID: 12005089
    [Abstract] [Full Text] [Related]

  • 16. High rate of breakthrough invasive aspergillosis among patients receiving caspofungin for persistent fever and neutropenia.
    Lafaurie M, Lapalu J, Raffoux E, Breton B, Lacroix C, Socié G, Porcher R, Ribaud P, Touratier S, Molina JM.
    Clin Microbiol Infect; 2010 Aug 15; 16(8):1191-6. PubMed ID: 19735276
    [Abstract] [Full Text] [Related]

  • 17. Liposomal amphotericin B twice weekly as antifungal prophylaxis in paediatric haematological malignancy patients.
    Bochennek K, Tramsen L, Schedler N, Becker M, Klingebiel T, Groll AH, Lehrnbecher T.
    Clin Microbiol Infect; 2011 Dec 15; 17(12):1868-74. PubMed ID: 21895857
    [Abstract] [Full Text] [Related]

  • 18. A randomized, double-blind, multicenter study of caspofungin versus liposomal amphotericin B for empiric antifungal therapy in pediatric patients with persistent fever and neutropenia.
    Maertens JA, Madero L, Reilly AF, Lehrnbecher T, Groll AH, Jafri HS, Green M, Nania JJ, Bourque MR, Wise BA, Strohmaier KM, Taylor AF, Kartsonis NA, Chow JW, Arndt CA, DePauw BE, Walsh TJ, Caspofungin Pediatric Study Group.
    Pediatr Infect Dis J; 2010 May 15; 29(5):415-20. PubMed ID: 20431381
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia.
    Walsh TJ, Teppler H, Donowitz GR, Maertens JA, Baden LR, Dmoszynska A, Cornely OA, Bourque MR, Lupinacci RJ, Sable CA, dePauw BE.
    N Engl J Med; 2004 Sep 30; 351(14):1391-402. PubMed ID: 15459300
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.